KPV 10mg | Longevity & Anti-Inflammatory | Vietnam Peptides

KPV 10mg — Alpha-MSH Derived Tripeptide for Anti-Inflammatory & Gut Barrier Research

KPV (Lysine-Proline-Valine) is the smallest active fragment of alpha-melanocyte-stimulating hormone (α-MSH), corresponding to its C-terminal tripeptide sequence (residues 11–13). First recognized for delivering potent anti-inflammatory signaling independent of α-MSH’s pigmentation and hormonal effects, KPV has become a focal point of research into gut barrier integrity, inflammatory bowel disease, and skin repair — offering a compact, receptor-independent route into the NF-κB inflammatory cascade.

Product Overview

KPV is a tripeptide composed of lysine, proline, and valine, derived from the C-terminus of α-MSH. Unlike the full-length hormone, KPV does not require binding to melanocortin receptors (MC1R–MC5R) to exert its effects, allowing it to act directly inside cells to suppress NF-κB activation and downstream pro-inflammatory cytokine production, including within intestinal epithelial and immune cells. This receptor-independent mechanism is why KPV is studied without the pigmentation changes or hormonal effects associated with its parent molecule.

Key Benefits

• NF-κB pathway inhibition — suppresses nuclear translocation of NF-κB, a master regulator of inflammatory gene expression
• Gut barrier support — studied for reducing colonic inflammation and preserving mucosal integrity in colitis models
• Cytokine modulation — downregulates TNF-α, IL-1β, IL-6, and IL-8 production in inflamed tissue
• Skin repair research — investigated in wound healing, psoriasis, and dermatitis models
• Antimicrobial interest — early research suggests activity against select bacterial and fungal strains
• No pigmentation effect — lacks the melanocortin receptor activity responsible for α-MSH’s tanning response
• Systemic inflammation research — studied in models of sepsis and broader inflammatory conditions

Popular Use Cases

KPV is studied in inflammatory bowel disease research (colitis and Crohn’s disease models), dermatological research (psoriasis, eczema, and wound healing), and broader immunology research examining NF-κB-driven inflammatory conditions. Its small size and oral bioavailability via the PepT1 transporter have also made it a subject of gut-targeted delivery research.

Who Commonly Uses This

Gastroenterology researchers, immunologists, dermatology researchers, and inflammation biologists represent the primary research communities studying KPV. Biohackers and precision wellness practitioners interested in gut health and systemic inflammation also reference KPV literature.

Product Details

Storage & Handling

Store lyophilized KPV at 2–8°C away from light. Avoid freeze-thaw cycles. Once reconstituted, store at 2–8°C and use within 28–30 days.

Research & Scientific Interest

KPV’s discovery as the minimal anti-inflammatory fragment of α-MSH reframed how researchers think about melanocortin biology, showing that potent NF-κB suppression can be achieved without engaging melanocortin receptors at all. Foundational work by Dalmasso et al. demonstrated that KPV is transported into intestinal epithelial cells via the PepT1 transporter, where it reduces colitis severity in animal models. Subsequent research has extended KPV’s relevance to skin inflammation, wound healing, and broader immune regulation, positioning it as a compact tool for studying inflammation at the cellular level.

Lifestyle & Wellness Context

KPV represents a precise, receptor-independent approach to inflammation research — a compact tripeptide that isolates the anti-inflammatory power of α-MSH from its hormonal effects. H&J Pharma supplies KPV 10mg at research grade with HPLC-verified purity and same-day shipping across Vietnam.

Related Wellness Research Areas

Research communities studying gut barrier biology, NF-κB signaling, dermatological repair, immune regulation, and inflammatory bowel disease will find KPV among the most targeted peptides in current anti-inflammatory research.